BRIEF-Ocugen Says Co And Bharat Entered Into That Certain First Amendment To Co-Development, Supply And Commercialization Agreement

Reuters2021-06-07

June 7 (Reuters) - Ocugen Inc :

* OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT CERTAIN FIRST AMENDMENT TO CO-DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT

* OCUGEN INC - PARTIES AGREED TO EXPAND THE ORIGINAL OCUGEN TERRITORY TO INCLUDE THE UNITED STATES AND CANADA

* OCUGEN INC - PAID TO BHARAT $15 MILLION IMMEDIATELY UPON EXECUTION OF THE AMENDMENT

* OCUGEN INC - FURTHER AGREED TO PAY TO BHARAT A MILESTONE PAYMENT OF $10 MILLION WITHIN 30 DAYS OF THE FIRST COMMERCIAL SALE OF COVAXIN IN CANADA.

* OCUGEN INC - PARTIES WILL SHARE ANY PROFITS GENERATED FROM THE COMMERCIALIZATION OF COVAXIN IN THE AMENDED OCUGEN TERRITORY

Source text () Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

BKZH
2021-06-08
BKZH
Buy buy buy

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2141239873?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-07 18:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2141239873","market":"us","top_or_hot":-1,"title":"BRIEF-Ocugen Says Co And Bharat Entered Into That Certain First Amendment To Co-Development, Supply And Commercialization Agreement","media":"Reuters","content":"<html><body><p>June 7 (Reuters) - Ocugen Inc   :</p><p>   * OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT CERTAIN FIRST AMENDMENT TO CO-DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT</p><p>   * OCUGEN INC - PARTIES AGREED TO EXPAND THE ORIGINAL OCUGEN TERRITORY TO INCLUDE THE UNITED STATES AND CANADA</p><p>   * OCUGEN INC -  PAID TO BHARAT $15 MILLION IMMEDIATELY UPON EXECUTION OF THE AMENDMENT</p><p>   * OCUGEN INC - FURTHER AGREED TO PAY TO BHARAT A MILESTONE PAYMENT OF $10 MILLION WITHIN 30 DAYS OF THE FIRST COMMERCIAL SALE OF COVAXIN IN CANADA.</p><p>   * OCUGEN INC -  PARTIES WILL SHARE ANY PROFITS GENERATED FROM THE COMMERCIALIZATION OF COVAXIN IN THE AMENDED OCUGEN TERRITORY</p><p>Source text () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ocugen Says Co And Bharat Entered Into That Certain First Amendment To Co-Development, Supply And Commercialization Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ocugen Says Co And Bharat Entered Into That Certain First Amendment To Co-Development, Supply And Commercialization Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 18:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>June 7 (Reuters) - Ocugen Inc   :   * OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT CERTAIN FIRST AMENDMENT TO CO-DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT   * OCUGEN INC - ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FNLC","symbol_name":"第一万通金控","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2141239873","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2141239873","pubTimestamp":1623062347,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"June 7 (Reuters) - Ocugen Inc   :   * OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"FNLC":"第一万通金控","THFF":"First Financial Corporation Indi","FBNC":"第一万能金控","FFBC":"第一金融银行股份","OCGN":"Ocugen"},"translate_title":"奥库根说，公司和巴拉特签署了《共同开发、供应和商业化协议》第一修正案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FBNC":1,"FFBC":1,"FNLC":1,"THFF":1,"OCGN":0.9},"content_text":"June 7 (Reuters) - Ocugen Inc   :   * OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT CERTAIN FIRST AMENDMENT TO CO-DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT   * OCUGEN INC - PARTIES AGREED TO EXPAND THE ORIGINAL OCUGEN TERRITORY TO INCLUDE THE UNITED STATES AND CANADA   * OCUGEN INC -  PAID TO BHARAT $15 MILLION IMMEDIATELY UPON EXECUTION OF THE AMENDMENT   * OCUGEN INC - FURTHER AGREED TO PAY TO BHARAT A MILESTONE PAYMENT OF $10 MILLION WITHIN 30 DAYS OF THE FIRST COMMERCIAL SALE OF COVAXIN IN CANADA.   * OCUGEN INC -  PARTIES WILL SHARE ANY PROFITS GENERATED FROM THE COMMERCIALIZATION OF COVAXIN IN THE AMENDED OCUGEN TERRITORYSource text () Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":117020613,"gmtCreate":1623110789532,"gmtModify":1704196155583,"author":{"id":"3572945992604664","authorId":"3572945992604664","name":"BKZH","avatar":"https://static.tigerbbs.com/3e399456296d456e84f8cea78347bf08","vip":1,"crmLevel":3,"crmLevelSwitch":1,"idStr":"3572945992604664","authorIdStr":"3572945992604664"},"htmlText":"Buy buy buy","listText":"Buy buy buy","text":"Buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117020613","repostId":2141239873,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2141239873"}